Douglas T. Sheehy - Net Worth and Insider Trading

Douglas T. Sheehy Net Worth

The estimated net worth of Douglas T. Sheehy is at least $2 Million dollars as of 2024-12-27. Douglas T. Sheehy is the See Remarks of Aimmune Therapeutics Inc and owns about 45,668 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $2 Million. Douglas T. Sheehy is also the SVP, General Counsel & Sec. of Codexis Inc and owns about 69,200 shares of Codexis Inc (CDXS) stock worth over $344,616. Details can be seen in Douglas T. Sheehy's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas T. Sheehy has not made any transactions after 2020-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Douglas T. Sheehy

To

Douglas T. Sheehy Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas T. Sheehy owns 2 companies in total, including Aimmune Therapeutics Inc (AIMT) , and Codexis Inc (CDXS) .

Click here to see the complete history of Douglas T. Sheehy’s form 4 insider trades.

Insider Ownership Summary of Douglas T. Sheehy

Ticker Comapny Transaction Date Type of Owner
AIMT Aimmune Therapeutics Inc 2020-10-10 See Remarks
CDXS Codexis Inc 2013-11-13 SVP & General Counsel & Sec.

Douglas T. Sheehy Latest Holdings Summary

Douglas T. Sheehy currently owns a total of 2 stocks. Among these stocks, Douglas T. Sheehy owns 45,668 shares of Aimmune Therapeutics Inc (AIMT) as of January 16, 2020, with a value of $2 Million and a weighting of 82.05%. Douglas T. Sheehy also owns 69,200 shares of Codexis Inc (CDXS) as of September 14, 2012, with a value of $344,616 and a weighting of 17.95%.

Latest Holdings of Douglas T. Sheehy

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AIMT Aimmune Therapeutics Inc 2020-01-16 45,668 34.49 1,575,089
CDXS Codexis Inc 2012-09-14 69,200 4.98 344,616

Holding Weightings of Douglas T. Sheehy


Douglas T. Sheehy Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas T. Sheehy has made a total of 1 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aimmune Therapeutics Inc is the sale of 400 shares on January 16, 2020, which brought Douglas T. Sheehy around $14,800.

According to the SEC Form 4 filings, Douglas T. Sheehy has made a total of 0 transactions in Codexis Inc (CDXS) over the past 5 years. The most-recent trade in Codexis Inc is the sale of 3,800 shares on September 14, 2012, which brought Douglas T. Sheehy around $10,488.

Insider Trading History of Douglas T. Sheehy

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas T. Sheehy Trading Performance

GuruFocus tracks the stock performance after each of Douglas T. Sheehy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas T. Sheehy is 28.63%. GuruFocus also compares Douglas T. Sheehy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas T. Sheehy within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Douglas T. Sheehy's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Douglas T. Sheehy

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.28 LIMIT LIMIT LIMIT LIMIT LIMIT

Douglas T. Sheehy Ownership Network

Ownership Network List of Douglas T. Sheehy

No Data

Ownership Network Relation of Douglas T. Sheehy

Insider Network Chart

Douglas T. Sheehy Owned Company Details

What does Aimmune Therapeutics Inc do?

Who are the key executives at Aimmune Therapeutics Inc?

Douglas T. Sheehy is the See Remarks of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .

Aimmune Therapeutics Inc (AIMT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aimmune Therapeutics Inc Insider Transactions

No Available Data

Douglas T. Sheehy Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas T. Sheehy. You might contact Douglas T. Sheehy via mailing address: C/o Aimmune Therapeutics, Inc., 8000 Marina Boulevard, Suite 300, Brisbane Ca 94005-1884.

Discussions on Douglas T. Sheehy

No discussions yet.